Tradestie Institutional Equity Comparison Engine
TCMD vs WOK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TCMD Overall Edge
TCMD Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TCMD trades at 17.9x Forward P/E with 9.4% operating margin (+7.1% YoY revenue) versus WOK at N/M Forward P/E and -41.7% operating margin (+19.1% YoY). In options structure, TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against WOK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
TCMD
TCMD 17.9x vs WOK N/M Fwd P/E
Growth & Margin Winner
TCMD
Op Margin 9.4% vs -41.7% ยท YoY +7.1% vs +19.1%
Momentum & Technical Winner
TCMD
1Y +8.2% vs -72.0% ยท 52W Pos 34% vs 16%
Options & Structure Winner
TCMD
CONSOLIDATION (15th %ile IV) vs UNCLASSIFIED (N/A IV)
TCMD
NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$26.37
-1.64% 1D
Market Cap
$600.6M
1M Return
+17.1%
1Y Return
+8.21%
Forward P/E
17.9x
Unified AI Score
25.2 / 100
SELL
Tech 50.0
Fund 28.0
Flow 66.0
Mom 21.4
WOK
NASDAQ
WORK Medical Technology Group LTD Class A Ordinary Shares
Surgical & Medical Instruments & Apparatus
$1.23
+2.5% 1D
Market Cap
$5.4M
1M Return
+12.84%
1Y Return
-72.05%
Forward P/E
N/M
Unified AI Score
25.6 / 100
SELL
Tech 5.0
Fund 39.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TCMD +8.21%
WOK -72.05%
Spread: +80.26 pp (TCMD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
TCMD TTM Op. Margin: 9.4%
WOK TTM Op. Margin: -41.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TCMD vs WOK. Trailing 12-month operating profitability (TCMD 9.4% vs WOK -41.7%) and valuation multiples (TCMD 17.9x vs WOK N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TCMD | WOK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $600.6M | $5.4M | Larger Scale | TCMD |
| Trailing P/E Ratio Valuation | 26.0x | N/M | Lower Multiple | TCMD |
| Forward P/E Ratio Valuation | 17.9x | N/M | Lower Multiple | TCMD |
| Revenue Growth (YoY) Growth | +7.1% | +19.1% | Higher Growth | WOK |
| Operating Margin (TTM) Profitability | 9.4% | -41.7% | Higher Margin | TCMD |
| Net Profit Margin Profitability | 6.7% | -41.9% | Higher Margin | TCMD |
| Return on Equity (ROE) Capital Efficiency | 11.0% | -19.2% | Higher ROE | TCMD |
| 52-Week Range Position Momentum | 34% ($21โ$38) | 16% ($0โ$7) | Stronger Trend | TCMD |
| Beta / 30D Volatility Risk Regime | 1.00ฮฒ ยท 53% Vol | 38.49ฮฒ ยท 153% Vol | Lower Realized Risk | TCMD |
| Unified Institutional Score Composite Signal | 25.2 / 100 (SELL) | 25.6 / 100 (SELL) | Higher Composite | WOK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TCMD vs WOK Buy Guide
TCMD
CONSOLIDATION
94d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
WOK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TCMD nor WOK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.